Table 2.
Baseline imaging findings according to cognitive outcome groups 3 months after acute stroke
| Normal cognition n = 103 |
Mild NCDd n = 63 |
Major NCD n = 65 |
Any NCD n = 128 |
Total n = 231 |
|
|---|---|---|---|---|---|
| Stroke volume (ml) - mean (SD) | 7 (10.8) | 4.1 (7) | 16.1 (27.7) | 10.2 (21.2) | 8.7 (17.4) |
| Stroke volume (ml) – median (IQR)a | 1.7 (0.5–9.1) | 1.7 (0.5–3.7) | 2.9 (0.7–21-1) | 1.9 (0.6–7.5) | 1.8 (0.2–5.3) |
| Hemorrhagic stroke - n (%) | 5 (4.6) | 7 (11.1) | 5 (7.7) | 12 (9.4) | 17 (7.4) |
| Left hemisphere – n (%) | 38 (37.6) | 33 (55) | 31 (47.7) | 64 (51.2) | 102 (45.1) |
| Both hemispheres – n (%) | 2 (2) | 3 (5) | 1 (1.5) | 4 (3.2) | 6 (2.7) |
| Strategic infarct - n (%) | 10 (9.7) | 6 (9.5) | 7 (10.8) | 13 (10.2) | 23 (9.9) |
| Pathologic WMHb score - n (%) | 27 (26.2) | 25 (39.7) | 38 (58.5) | 63 (49.2) | 90 (39) |
| Pathologic MTAc score - n (%) | 28 (27.2) | 27 (42.9) | 27 (41.5) | 54 (42.2) | 82 (35.5) |
aIQR Inter quartile range, bWMH White matter hyperintensities. cMTA Medial temporal lobe atrophy. dNCD Neurocognitive disorder